Picture of ImmuPharma logo

IMM ImmuPharma Balance Sheet

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for ImmuPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments4.911.365.861.650.668
Net Total Accounts Receivable
Net Total Receivables0.9440.7090.4821.131.34
Prepaid Expenses
Total Other Current Assets
Total Current Assets6.013.587.433.352.34
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.1650.2070.4120.3530.39
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets8.665.810.963.97
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.010.5321.261.581.45
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1.030.5321.261.581.45
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity7.625.279.654.412.52
Total Liabilities & Shareholders' Equity8.665.810.963.97
Total Common Shares Outstanding